mail2

Press

Chugai SAkuraSky Phase III Results

By The Guthy-Jackson Charitable Foundation | October 23, 2018 | 0 Comments

October 23, 2018 | Beverly Hills, CA — Chugai Pharmaceutical Co. announced positive results from one of its phase III clinical trials of satralizumab (SA237),…

Alexion Prevent Phase 3 Results

By The Guthy-Jackson Charitable Foundation | September 25, 2018 | 0 Comments

September 25, 2018 | Beverly Hills, CA — The Guthy-Jackson Charitable Foundation (GJCF) congratulates Alexion Pharmaceuticals on their announcement of positive results from the PREVENT…

The Guthy-Jackson Charitable Foundation Welcomes Christopher Clinton Conway as Executive Director

By The Guthy-Jackson Charitable Foundation | August 9, 2018 | 0 Comments

The Guthy-Jackson Charitable Foundation is pleased to welcome Christopher Clinton Conway in the newly-created position of Executive Director. Mr. Conway will serve as a highly-visible…